64th Annual Scientific Meeting
Register for the On Demand Experience
WHO SHOULD ATTEND?
The Annual Scientific Meeting is designed for physicians, psychologists, scientists, researchers, physician assistants, nurse practitioners, and other health professionals involved in the care of patients with head, neck, and orofacial pain.
AHS has dedicated over 60 years to leading and serving the headache community.
THE AMERICAN HEADACHE SOCIETY’S® ANNUAL SCIENTIFIC MEETING continues to be the premier venue for the dissemination of the latest and most up-to-date research and scientific advances underlying the practice of Headache Medicine.
View a welcome message from Visit Aurora and plan your trip here!
HEALTH AND SAFETY
The American Headache Society® (AHS) is actively monitoring the health and safety guidance from the Centers for Disease Control as well as state and local health departments. AHS requires attendees to abide by any applicable rules of conduct or local or state laws that may be announced at any time before or during the event.
All attendees, speakers, and exhibitors are required to be vaccinated against the COVID-19 virus at least 14 days prior to arriving for the event, including recommended booster shots.
When picking up badges, each participant will need to provide proof of vaccination (a vaccine card or a phone picture) with a vaccine approved by the U.S. Food and Drug Administration (FDA) or the World Health Organization (WHO). These include Pfizer-BioNTech, Johnson and Johnson’s Janssen, Moderna, AstraZeneca-Oxford, and Sinopharm. If you do not have proof of vaccination during arrival, it could result in delays.
Unvaccinated participants are welcome to still participate in the meeting by registering for the virtual option. Anyone who is registered for in-person attendance and would like to switch to virtual attendance can email AHS at any point.
Masks are required for all participants while inside the meeting space, with the exception of during eating or drinking. Masks are encouraged during outdoor events as well.
Social Distancing will be encouraged and seating during sessions will be spread out to allow for more personal space.
PLENARY PALS PROGRAM
If this is your first time at The Annual Scientific Meeting®, sign up for the Plenary Pals program during registration and to be paired with an experienced attendee who can help guide you through the agenda and meet with you onsite to make sure your experience is fantastic!
SPECIAL NOTE FOR THE PHYSICALLY CHALLENGED
The American Headache Society® wishes to take steps to ensure that no individual with a disability is excluded, denied services, segregated, or otherwise treated differently than other individuals because of the absence of auxiliary aids and services. If you need any auxiliary aids or services identified in the Americans with Disabilities Act, or any assistance in registering for this symposium, please contact AHS Headquarters at 856-423-0043, write to us at AHS, 19 Mantua Road, Mt. Royal, NJ, 08061, or email AHSHQ@talley.com.
64th Annual Scientific Meeting
PURPOSE/OBJECTIVE
At the conclusion of the program, participants will be able to:
- Describe novel therapeutic targets for headache disorders and their mechanism of action
- Utilize headache research techniques to interpret the results of basic science studies and clinical trials
- Incorporate the role of comorbidities in the management of headache disorders
- Discuss recent research in post-traumatic headache
ACCREDITATION STATEMENT
The American Headache Society® is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
The American Headache Society® designates this Other (live and recorded sessions) activity for a maximum of 34.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
INSTRUCTIONS FOR CLAIMING CME
- Please note: The maximum number of credits is calculated based on attending all live sessions and then watching concurrent sessions as recordings later
- We suggest you wait to complete the evaluation/claim credit until you’ve watched all recording sessions for which credit is sought
- Complete the post-activity evaluation
- A certificate of completion will be available once the evaluation is submitted
FINANCIAL DISCLOSURES
The planners and faculty for this activity did not have any relationships to disclose unless listed here. All relevant relationships were mitigated prior to the start of the activity according to ACCME Standards.
DISCLOSURE OF COMMERCIAL SUPPORT
The American Headache Society® received funding to support this activity from the following organizations:
Lilly USA, LLC
Lundbeck LLC
64th Annual Scientific Meeting
Register for the On Demand Experience
Registration will take place online only. If you need assistance or have multiple attendees from your organization to register, please contact the AHS office.
REGISTRATION CATEGORIES AND FEES*
| Early Bird Rate
Before April 8 |
Regular Rate
April 8 – June 7 |
Late/Onsite Rate
After June 7 |
|
| Active Member/Non-Member (MD, DO, PhD, DDS, PharmD) | $525/$675 | $575/$750 | $825/$1,000 |
| Associate Member/Non-Member (RN, NP, PA) | $250/$300 | $300/$350 | $550/$600 |
| AHS Trainee Member/Non-Member | $150/$200 | $150/$200 | $450/$450 |
| Active Military Personnel | $450 | $450 | $500 |
| Industry Representative | $675 | $750 | $1,000 |
PRE-COURSE REGISTRATION FEES
| Early Bird Rate
Before April 8 |
Regular Rate
April 8 – June 7 |
Late/Onsite Rate
After June 7 |
|
| AHS Member | Complimentary | Complimentary | Complimentary |
| Non-Member | $300 | $350 | $500 |
*Prices are for either In-Person or Virtual experiences. All In-Person attendees will also have access to the Virtual experience.
REGISTRATION INFORMATION
Meeting registration includes all educational sessions (except where noted), the exhibit hall, continental breakfast and refreshment breaks each day, as well as several evening receptions during the event.
HEALTH AND SAFETY
The American Headache Society® (AHS) is actively monitoring the health and safety guidance from the Centers for Disease Control as well as state and local health departments. AHS requires attendees to abide by any applicable rules of conduct or local or state laws that may be announced at any time before or during the event, which may include wearing personal protective gear, engaging in social distancing, agreeing to temperature checks or COVID-19 testing requirements, or providing proof of COVID-19 vaccination status. More information on the health and safety plan for this event will be published closer to the start of the event.
All registrants will have to attest to being fully vaccinated (including recommended booster shots) at least two weeks prior to arriving for the event. Additionally, you may have to produce proof of vaccination when you arrive at the meeting.
FORMS OF PAYMENT
Checks are acceptable when registration is submitted by mail or completed onsite at the 64th Annual Scientific meeting. Checks must be made payable (in US dollars) to the American Headache Society and issued by a US correspondent bank. The registrant is responsible for all bank charges. Mail to:
American Headache Society
2022 Annual Scientific Meeting Registration
19 Mantua Road
Mount Royal, NJ 08061
Credit Cards are the preferred method of payment. AHS accepts Visa, MasterCard, and American Express. AHS reserves the right to charge the correct amount, if different from your calculated total. Charges will appear on your statement as “AHS Registration.”
Wire Transfers are accepted provided that the NET AMOUNT of the wire (after bank fees) is sufficient to cover all registration fees in US dollars. Please contact AHS Registration (856-423-0043 or ahshq@talley.com) for additional information on wire transfer payments.
Cash and Travelers Checks (US dollars only) are accepted for onsite registration at the Annual Meeting. Please do not send cash or traveler’s checks through the mail.
Group Discounts
AHS encourages you and your colleagues to take advantage of the discounted fees available when two or more employees from an organization (same location) register for the meeting. Registration for group discounts must be submitted together. A discount of $25.00 per attendee (after the first attendee pays full price) will be applied. Please contact AHS Registration (856-423-0043 or ahshq@talley.com) to get a discount code for groups.
Letters of Invitation
If requested, the AHS will send a personal invitation for participation at the 64th Annual Scientific Meeting. This invitation is only meant to assist participants in raising travel funds and obtaining a VISA. This is not a commitment on the part of the AHS to provide any financial support.
Cancellation Policy
Requests must be submitted via email no later than Thursday, May 26, 2022. Once the cancellation is processed, all fees paid will be refunded. If paid by credit card, please allow up to five business days for the credit to show in your bank account. THERE WILL BE NO REFUNDS AFTER THE MAY 26th DEADLINE.
Substitutions will be accepted until May 26, 2021. For cancelations, substitutions, or experience changes, please contact: ahshq@talley.com
Moving From In-Person Experience To Virtual Experience
Attendees wishing to move from the In-Person to Virtual Experience due to health, inability, or discomfort with traveling may change their registration at any point with no penalty. Please email the AHS office (ahshq@talley.com) to request the change.
64th Annual Scientific Meeting
Sessions, Speakers, and Times may change.
Thursday, June 9, 2022
| 6:00 am – 6:30 am | Sunrise Yoga |
| 7:00 am – 6:00 pm | Registration Desk |
| 7:00 am – 8:00 am | Industry-Sponsored Event
Women in Headache Medicine Breakfast Sponsored by AbbVie, Inc. Not Eligible for CME Credits |
| 8:00 am – 10:00 am | Pre-Meeting Courses |
| Pre-Course 1: | Trials and Tribulations: Optimizing and Expanding Headache Services for Your Patients
Practice Management Committee
Moderators: Christina L. Szperka, MD, FAHS; Raissa Villanueva, MD, MPH |
| 8:00 am – 8:05 am | Introductions
Christina L. Szperka, MD, FAHS Children’s Hospital of Philadelphia
Raissa Villanueva, MD, MPH University of Rochester Medical Center |
| 8:05 am – 8:35 am | How to Get Involved in Clinical Trials
Jessica Ailani, MD, FAHS MedStar Georgetown University Hospital
Brad C. Klein, MD, MBA Abington Neurological Associates, LTD |
| 8:35 am – 8:55 am | How to Build a Multi-Disciplinary Team
Brian M. Grosberg, MD Hartford Healthcare Headache Center |
| 8:55 am – 9:05 am | Billing/Reimbursement for Psychologists, Working Together
Elizabeth K. Seng, PhD, FAHS Yeshiva University/Albert Einstein College of Medicine |
| 9:05 am – 9:15 am | Billing/Reimbursement for APPs/RNs and the Logistics of How to Work Together Efficiently
Maureen A. Moriarty, DNP, ANP-BC, FAHS Moriarty Associates |
| 9:15 am – 9:35 am | Prior Authorization- Navigating the Process
Raissa Villanueva, MD, MPH University of Rochester Medical Center |
| 9:35 am – 9:45 am | Special Issues in Pediatrics
Christina L. Szperka, MD, FAHS Children’s Hospital of Philadelphia |
| 9:45 am – 10:00 am | Panel Discussion |
| Pre-Course 2: | The Surgical Management of Headache: Cutting Edge Approaches and Controversies
CSF Pressure and Volume Disorders and Procedural Headache Medicine Special Interest Sections
Moderator: Paul G. Mathew, MD, DNBPAS, FAHS |
| 8:00 am – 8:25 am | ENT Surgical Approaches in Patients with Headache Disorders
Frederick Godley III, MD, FACS Association of Migraine Disorders |
| 8:25 am – 8:50 am | Percutaneous And Surgical Approaches CSF Volume Disorders
Linda Gray Leithe, MD Duke University Medical Center |
| 8:50 am – 9:15 am | Bariatric Surgery and Headache
Jennifer McVige, MD, MA Dent Neurologic Institute |
| 9:15 am – 9:40 am | Nerve Decompression Surgery for the Treatment of Focal Painful Cranial Neuralgias
Pamela Blake, MD, FAHS Headache Center of River Oaks |
| 9:40 am – 10:00 am | Panel Discussion |
| 8:00 am – 12:30 pm | Hot Topics in Basic Science Symposium
Moderators: Amynah Pradhan, PhD; Rami Burstein, PhD |
| 8:00 am – 8:25 am | Novel Insights into Migraine Mechanisms from Multi-Modal Minimally Invasive Approach
Andrew C. Charles, MD, FAHS University of California, Los Angeles |
| 8:25 am – 8:50 am | Piloting a Phosphoproteome Analysis of Migraine Serum
Tally Largent-Milnes, PhD University of Arizona |
| 8:50 am – 9:15 am | Circadian Properties of Cluster Headache Medications and The Trigeminal Ganglion
Mark J. Burish, MD, PhD University of Texas Health Science Center at Houston |
| 9:15 am – 9:40 am | Uncovering a Neuroendocrine Link to Female-Selective Nociceptor Sensitization in Migraine
Caroline Kopruszinski, PhD University of Arizona |
| 9:40 am – 10:05 am | Human and Mouse Trigeminal Ganglia Cell Atlas Implicates Multiple Cell Types in Migraine
William Renthal, MD, PhD Brigham and Women’s Hospital |
| 10:05 am – 10:20 am | Hot Topics Panel Discussion |
| 10:20 am – 10:40 am | Break |
| 10:40 am – 11:05 am | Brain Functions Altered by Peripherally Acting Drugs
Rami Burstein, PhD Harvard Medical School |
| 11:05 am – 12:00 pm | Data Blitz Presentations
DB-01: Oxytocin Receptors on Calvarial Periosteal Nociceptors: Pain Modulation in a Model of Post-Traumatic Headache Vimala Bharadwaj, PhD Stanford University
DB-02: Structure-function Studies of Sodium, Potassium-ATPase Regulators in Migraine Veronica Hubble, PhD Huntington Medical Research Institutes
DB-03: Pharmacogenomics—One Step Closer to Precision Medicine in Headache? A Pilot, Exploratory Study of the Effect of Pharmacogenomic Phenotypes on the Adequate Dosing of Verapamil for Migraine Prevention Yi-Chieh Chen, PharmD Mayo Clinic Health System
DB-04: Differential Association of Plasma Hormones with Lipolysis in Chronic Migraine Alfred Fonteh, PhD Huntington Medical Research Institute
DB-05: Assessing the Mechanistic Processes of Sodium Dysregulation in Migraine Patients Abush Kolko, BS University of California, Santa Barbara
DB-06: Effects of Goreisan, an Herbal Medicine, on Cortical Spreading Depolarization Chisato Iba Keio University School of Medicine
DB-07: Sex Differences in Behavioral Reaction in a Rodent Model of Acute Migraine Chenchen Xia, PhD Huntington Medical Research Institutes |
| 12:00 pm – 12:30 pm | Group Discussion: Future of Basic Science of Headache
Chair: Rami Burstein, PhD Harvard Medical School |
| 10:30 am – 12:30 pm | Pacific Rim Symposium
How are CGRP-Related Monoclonal Antibodies Changing Migraine Therapy in the Pacific Rim Countries? Pacific Rim Committee
Moderators: Mamoru Shibata, MD, PhD
Overview: How Do We Effectively Utilize CGRP-Related Antibodies in Migraine Prophylaxis? Mamoru Shibata, MD, PhD Tokyo Dental College Ichikawa General Hospital
Galcanezumab for Difficult-To-Treat Chronic Migraine: Real-World Experience in Taiwan Yen-Feng Wang, MD, PhD National Yang-Ming University School of Medicine
Monoclonal Antibodies That Work on the CGRP Pathway – The Australian Experience Michael Eller, MD Monash Medical Centre
Clinical Experience of CGRP Monoclonal Antibodies in Korea Hong-Kyun Park, MD, MSc Inje University
Real-World Impact of Calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibodies in Japan: A New Era Of Migraine Therapy Daisuke Danno, MD, PhD Tominaga Hospital |
| 10:30 am – 12:30 pm | Pre-Meeting Courses |
| Pre-Course 3: | The Evidence-Free Zones of Pediatric Headache Treatments
Behavioral Issues, Complementary & Integrative Medicine, and Pediatric & Adolescent Special Interest Sections
Moderators: Christina L. Szperka, MD, FAHS; Emily Law, PhD; Niushen Zhang, MD, FAHS |
| 10:30 am – 10:35 am | Introductions by the Chairs
Christina L. Szperka, MD, FAHS; Emily Law, PhD; Niushen Zhang, MD, FAHS |
| 10:35 am – 10:55 am | Part 1: Treatments for Patients with NDPH and other Continuous Headache Disorders (Medications, CBD, Restrictive Diets, Chiropractic, Surgeries) – Considering Benefits and Harms
Jennifer Hranilovich, MD Children’s Hospital Colorado |
| 10:55 am – 11:05 am | Q&A |
| 11:05 am – 11:35 am | Part 2: Lifestyle Advice (Sleep, Hydration, Diet, Screen Time, Exercise), a Debate
Lifestyle Recommendations are Beneficial for Headache Care Lauren Natbony, MD Icahn School of Medicine at Mount Sinai
Lifestyle Recommendations Blame the Patient Kaitlin Greene, MD Oregon Health & Science University |
| 11:35 am – 12:00 pm | Summary of Lifestyle Recommendations and Q&A |
| 12:00 pm – 12:20 pm | Part 3: The State of Research in Pediatric Headache – from Bench to Clinical to Advocacy – Where Have We Been and Where are We Going?
Serena Orr, MD, MS, FAHS Alberta Children’s Hospital |
| 12:20 pm – 12:30 pm | Q&A |
| Pre-Course 4: | Understanding Patient-Reported Outcome Measures (PROMs) for Headache Trials and Clinical Practice
Methodology, Design & Statistical Issues Special Interest Section
Moderators: Olivia Begasse de Dhaem, MD; Dawn C. Buse, PhD, FAHS |
| 10:30 am – 10:55 am | “Fit-for-Purpose” PROMs From a Regulatory Standpoint
Jim McGinley, PhD Vector Psychometric Group, LLC |
| 10:55 am – 11:20 am | Measuring What Matters: Putting the Patient in PROMs
Rikki Mangrum, MLS Vector Psychometric Group, LLC |
| 11:20 am – 11:45 am | Key Quantitative Components Needed for Producing Fit-for-Purpose PROMs
Carrie R. Houts, PhD Vector Psychometric Group, LLC |
| 11:45 am – 12:10 pm | How to Select and Effectively Incorporate PROMs into Clinical Practice and Trials
Richard B. Lipton, MD, FAHS Albert Einstein College of Medicine |
| 12:10 pm – 12:30 pm | Panel Discussion
RJ Wirth, PhD Vector Psychometric Group, LLC
Dawn C. Buse, PhD, FAHS Albert Einstein College of Medicine
Katie Golden Patient Advocate |
| 12:30 pm – 1:30 pm | Industry-Sponsored Event
Patient and Clinician Perspectives in the Use of Modern Therapies for the Management of Migraine Sponsored by Lilly CME Eligible (via sponsor)
Jessica Ailani, MD, FAHS MedStar Georgetown University Hospital
Stephanie J. Nahas, MD, FAHS Thomas Jefferson University
Stewart J. Tepper, MD, FAHS Dartmouth-Hitchcock Medical Center |
| 2:00 pm – 2:30 pm | Welcome / Opening Remarks / AMF Update |
| 2:30 pm – 3:15 pm | KEYNOTE
Therapeutic Potential of Psychedelics Bryan Roth, MD, PhD University of North Carolina |
| 3:15 pm – 4:30 pm | PLENARY: Hot Topics in Headache
Moderator: Mark J. Burish, MD, PhD |
| 3:15 pm – 3:20 pm | Introductions
Nathaniel M. Schuster, MD University of California, San Diego |
| 3:20 pm – 3:40 pm | Psychedelics and Clinical Trials: What is the Data for Primary Headache Disorders?
Emmanuelle Schindler, MD, PhD Yale University |
| 3:40 pm – 3:45 pm | Q&A |
| 3:45 pm – 4:05 pm | How Does the Endocannabinoid System Affect Headache and Disorders?
Tally Largent-Milnes, PhD University of Arizona |
| 4:05 pm – 4:30 pm | Panel Discussion |
| 4:45 pm – 5:30 pm | AHS Membership Meeting
Not Eligible for CME Credits Open to AHS Members Only
Board of Directors Transition Member’s Choice Award “Management of Primary Headaches During Pregnancy, Postpartum, And Breastfeeding: A Systematic Review” Kenneth K. Chen, MD Brown University
Above and Beyond Awards Duren Michael Ready, MD, FAHS Baylor Scott & White Clinic
Stephanie J. Nahas, MD, FAHS Thomas Jefferson University
Adam Sprouse Blum, MD University of Vermont Medical Center
Distinguished Service Award William B. Young, Jr, MD Thomas Jefferson University
Runnin’ for Research Advocacy Award Anastasia Railean, MD Atrium Health Wake Forest Baptist |
| 5:30 pm – 6:45 pm | Welcome/Exhibitor/Poster Reception |
| 6:45 pm – 7:45 pm | Industry-Sponsored Event
A Portfolio of Treatments for Migraine Patients Sponsored by AbbVie, Inc. Not Eligible for CME Credits |
Friday, June 10, 2022
| 6:00 am – 6:30 am | Sunrise Yoga |
| 6:30 am – 8:00 am | Exhibits and Posters with Continental Breakfast |
| 6:30 am – 7:30 am | Industry-Sponsored Event
An Oral Formulation for the Acute Treatment of Migraine With or Without Aura Sponsored by Collegium Pharmaceutical Not Eligible for CME Credits
Andrew Blumenfeld, MD The Los Angeles and San Diego Headache Centers
Please join us to learn more about an oral formulation for the acute treatment of migraine with or without aura. |
| 6:30 am – 7:30 am | Industry-Sponsored Event
A Guided Discussion: AJOVY The Long-Acting Anti-CGRP Injection with Lasting Protection Against Migraine Sponsored by Teva Not Eligible for CME Credits |
| 7:00 am – 8:00 pm | AHS Executive Office |
| 7:00 am – 6:00 pm | Press Office |
| 8:00 am – 8:45 am | Seymour Solomon Award Lecture |
| Introduction: Seymour Solomon
Black Patients Matter in Headache Medicine: Exploration of Race, Racism, Race-based Headache Disparities and Professional Ethics Larry Charleston, IV, MD, MSc, FAHS Michigan State University College of Human Medicine |
|
| 8:45 am – 9:00 am | Lifetime Achievement Award
Introduction: Andrew C. Charles, MD, FAHS |
|
Gretchen E. Tietjen, MD University of Toledo |
|
| 9:00 am – 9:15 am | NIH Roadmap for Migraine Research Update
Michael L. Oshinsky, PhD NINDS/NIH |
| 9:15 am – 10:30 am
9:15 am – 9:35 am
9:35 am – 9:55 am
9:55 am – 10:10 am
10:10 am – 10:25 am |
Future of Headache Medicine
Clinical Fellowship Award Implementing Screening and Treatment for Adverse Childhood Experiences in Pediatric Patients with Headache at the Children’s Hospital of Philadelphia Marissa Anto, MD, MSc Children’s Hospital of Philadelphia
IHA Research Grant Presentation Examining the Impact of the Sleep-Wake Cycle and Sleep Deprivation on Cortical Spreading Depression Susceptibility and Sensory Sensitivity Sinifunanya Nwaobi, MD, PhD University of California, Los Angeles
Future Of Headache Medicine Voluntary Exercise Reduces Acute and Persistent Post-Traumatic Headache-Related Pain in a Rodent Model Vimala Bharadwaj, PhD Stanford University
Future Of Headache Medicine (FOMH-02) Presentation of Headache and Its Management in the Emergency Department Amongst a Cohort of Diverse Reproductive Age Women Crystal Jicha, MD Montefiore Headache Center |
| 10:30 am – 11:15 am | Exhibits and Posters with Refreshments |
| 11:15 am – 1:00 pm | Scientific Paper Presentations – Session 1
Moderators: Jessica Ailani, MD, FAHS; Matthew S. Robbins, MD, FAHS |
| 11:15 am – 11:25 am | OR-01: Migraine Prevalence Has Remained Stable While Disability Has Increased in US Population Studies
Fred Cohen, MD Jefferson Headache Center |
| 11:25 am – 11:35 am | OR-02: The NIH HEAL Initiative Preclinical Screening Platform for Pain (PSPP) Efforts to Validate Rodent Models of Pain and Migraine
Smriti Iyengar, PhD NINDS/NIH |
| 11:35 am – 11:45 am | OR-03: Therapeutic Potential of Cannabinoids on Preclinical Migraine Models
Erik Zorrilla, BS University of Iowa |
| 11:45 am – 11:55 am | OR-04: Resting-State Functional Connectivity in Pediatric Patients With New Daily Persistent Headache
Edina Szabo, PhD Boston Children’s Hospital, Harvard Medical School |
| 11:55 am – 12:05 pm | OR-05: Implementation of a Best Practice Alert in the Electronic Health Record Reduced Neurology Referrals and Magnetic Resonance Imaging for Headache: A Pilot Program of 1,860 Patients
Scott M. Friedenberg, MD Geisinger Health System |
| 12:05 pm – 12:15 pm | OR-06: Validity of Self-Reported Migraine in Adolescents and Children
Danielle J. Kellier, BS University of Pennsylvania |
| 12:15 pm – 12:25 pm | OR-07: Precision Phenotyping in Migraine Using Topological Data Analysis – Visualizing the Spectrum of Migraine Clinical Features
Chia-Chun Chiang, MD Mayo Clinic |
| 12:25 pm – 12:35 pm | OR-08: Symptoms of Increased Peripheral and Central Trigeminal Sensitization Predict the Response to antiCGRP Monoclonal Antibodies: A Multicenter, 24-Week, Cohort Study on 864 Migraine Patients
Piero Barbanti, MD, PhD IRCCS San Raffaele Roma |
| 12:35 pm – 1:00 pm | Frontiers in Headache Research Scholarship Lecture+ Award Presentation
Mechanisms of Mindfulness’ Impact on Migraine After Mindfulness Based Stress Reduction Paige Estave, PhD Wake Forest School of Medicine |
| 1:00 pm – 1:30 pm | Early Career Award Lecture
Introduction: Matthew S. Robbins, MD, FAHS |
|
Migraine with Aura Associates with A Higher Artificial Intelligence- ECG Atrial Fibrillation Prediction Model Output Compared to Migraine without Aura in Both Women and Men Chia-Chun Chiang, MD Mayo Clinic |
|
| 1:30 pm – 2:30 pm | Exhibits and Poster Session
Lunch Available for Purchase |
| 1:30 pm – 2:30 pm | Industry-Sponsored Event
Mechanism of Action in Migraine Therapeutics: Does It Matter to Clinicians and Patients? Sponsored by Lilly Not Eligible for CME Credits
Jessica Ailani, MD, FAHS MedStar Georgetown University Hospital
Peter J. Goadsby, MD, PhD, FAHS University of California, Los Angeles
Paul G. Mathew, MD, DNBPAS, FAHS Harvard Medical School |
| 2:30 pm – 3:15 pm | Harold G. Wolff Award Lecture
Introduction: Matthew S. Robbins, MD, FAHS |
| Migraine and Peripheral Pain Models Show Differential Alterations in Neuronal Complexity
Amynah A. Pradhan, PhD University of Illinois at Chicago |
|
| 3:15 pm – 5:15 pm | PLENARY: Design and Interpretation of Headache Research and Clinical Trials
Moderator: Elizabeth K. Seng, PhD, FAHS Chair: Jessica Ailani, MD, FAHS |
| 3:15 pm – 3:20 pm | Introductions
Robert C. Gibler, PhD Cincinnati Children’s Hospital Medical Center |
| 3:20 pm – 3:40 pm | Animal Modeling of Headache and Design Implementation
Amynah A. Pradhan, PhD University of Illinois Chicago |
| 3:40 pm – 3:45 pm | Q&A |
| 3:45 pm – 4:05 pm | The Pitfalls of Unreliable or Missing Data
Dana Turner, PhD, MSPH Massachusetts General Research Institute |
| 4:05 pm – 4:10 pm | Q&A |
| 4:10 pm – 4:30 pm | What Should be the Primary Outcome?
R.J. Wirth, PhD Vector Psychometric Group, LLC |
| 4:30 pm – 4:35 pm | Q&A |
| 4:35 pm – 4:55 pm | Setting the Criteria for Selection of Clinical Trials
Jessica Ailani, MD, FAHS MedStar Georgetown University Hospital |
| 4:55 pm – 5:15 pm | Panel Discussion |
| 5:15 pm – 7:15 pm | Friday Evening Events |
| 5:15 pm – 5:45 pm | Special Interest Section Fair |
| 5:45 pm – 7:15 pm | AHS’ Got Talent |
| 7:30 pm – 8:30 pm | Industry-Sponsored Event
Treat and Prevent Migraines with an All-in-One Medication Sponsored by Biohaven Pharmaceuticals Not Eligible for CME Credits
Peter McAllister, MD New England Center for Neurology and Headache |
Saturday, June 11, 2022
| 6:00 am – 6:30 am | Sunrise Yoga |
| 6:30 am – 5:30 pm | Registration Desk |
| 6:30 am – 7:30 am | Exhibits and Posters with Continental Breakfast |
| 6:30 am – 7:30 am | Industry-Sponsored Event
Starting Today Effects of a Preventive Treatment Initiated During a Migraine Attack Sponsored by Lundbeck Not Eligible for CME Credits
Dawn C. Buse, PhD, FAHS Albert Einstein College of Medicine
Rami Apelian, MD, MPH, FAES Huntington Headache & Neurology
Paul K. Winner, DO, FAAN, FAAP, FAHS Palm Beach Headache Center |
| 7:30 am – 9:30 am | Industry-Submitted Abstracts
Not Eligible for CME Credits |
| 7:30 am – 7:40 am | IOR-01: Efficacy And Safety Of Zavegepant Nasal Spray for the Acute Treatment of Migraine: Results of a Phase 3 Double-Blind, Randomized, Placebo Controlled Trial
Jelena M. Pavlovic, MD, PhD Albert Einstein College of Medicine/ Montefiore Headache Center |
| 7:40 am – 7:50 am | IOR-02: Incidences of Traumatic Brain Injury and Post-Traumatic Headache for all Age Groups Using a US Claims Database
Juline Bryson, MD Teva |
| 7:50 am – 8:00 am | IOR-03: Migraine-Related Stigma and Its Influence on Disability, Interictal Burden, and Migraine Specific Quality of Life: Results of the OVERCOME (US) Study
Robert E. Shapiro, MD, PhD Larner College of Medicine, University of Vermont |
| 8:00 am – 8:10 am | IOR-04: Increased Placebo Response Over Time in Oral Migraine Preventive Trials: A Systematic Literature Review and Meta-Analysis
Stewart J. Tepper, MD, FAHS Dartmouth-Hitchcock Medical Center |
| 8:10 am – 8:20 am | IOR-05: Characterizing Preventive Treatment Gaps in Migraine: Interim Results From the CaMEO-International Study United States Sample
Dawn C. Buse, PhD, FAHS Albert Einstein College of Medicine |
| 8:20 am – 8:30 am | IOR-06: Cardiovascular Outcomes Associated With Oral Triptans Among Migraine Patients With a History of Cardiovascular Conditions
Jessica Ailani, MD, FAHS MedStar Georgetown University Hospital |
| 8:30 am – 8:40 am | IOR-07: A Multicenter, Open Label Study Assessing the Efficacy of AJOVY® (fremanezumab-vfrm) on Interictal Migraine Related Burden
Heather Manley, MS, LPC |
| 8:40 am – 8:50 am | IOR-08: Long-Term Safety and Tolerability of STS101, a Dry Powder Intranasal Dihydroergotamine Product: Initial Data From the ASCEND Study
Stewart J. Tepper, MD, FAHS Dartmouth-Hitchcock Medical Center |
| 8:50 am – 9:00 am | IOR-09: Safety and Tolerability of Rimegepant Every Other Day for Preventive Treatment of Migraine Plus As-Needed for Acute Treatment of Migraine: Results from A 52-Week, Open-Label Extension Study
Richard B. Lipton, MD, FAHS |
| 9:00 am – 9:10 am | IOR-10: Early Prediction of Response to INP104 for the Acute Treatment of Migraine
Sara E. Sacco, MD Carolinas Headache Clinic |
| 9:10 am – 9:20 am | IOR-11: Decrease in Body Weight With Once-Daily Atogepant for the Preventive Treatment of Migraine: A Post Hoc Analysis
Jessica Ailani, MD, FAHS MedStar Georgetown University Hospital |
| 9:20 am – 9:30 am | IOR-12: Celecoxib Oral Solution in the Acute Treatment of Migraine: Pooled Efficacy and Safety Results From 2 Randomized Placebo-controlled Trials
Stewart J. Tepper, MD, FAHS Dartmouth-Hitchcock Medical Center |
| 9:30 am – 10:00 am | Coffee Break |
| 10:00 am – 10:45 am | DEBATE: Positive Phase 3 Trial: ‘So what?’ OR ‘That’s awesome!’ Are Clinical Trials Representative of our Patients?
Chairs: Christina L. Szperka, MD, FAHS; Deborah I. Friedman, MD, MPH, FAHS
Jan L. Brandes, MD Nashville Neuroscience Group
Amy Gelfand, MD, FAHS University of California, San Francisco |
| 10:45 am – 11:15 am | Exhibits and Posters with Refreshments |
| 11:15 am – 12:15 pm | CONCURRENT SESSION
Scientific Paper Presentations – Session 2A |
| 11:15 am – 11:25 am | OR-09: Injection of CGRP in the Medial Cerebellar Nucleus Alters Sensory but Not Motor Behaviors
Thomas Duong University of Iowa |
| 11:25 am – 11:35 am | OR-10: Efficacy of a Dual ENKephalinase Inhibitor in a Preclinical Stress-Induced Migraine Model
Hao-Ruei Mei University of Texas at Dallas |
| 11:35 am – 11:45 am | OR-11: Migraine During Fertility Treatment: Interim Analysis of a Pilot Study
Joseph Safdieh Weill Cornell Medicine |
| 11:45 am – 11:55 am | OR-12: Sex Differences in Migraine: A Twin Study
Morgan C. Fitzgerald, BS University of California San Diego |
| 11:55 am – 12:05 pm | OR-13: The Migraine Disability Assessment (MIDAS) as an Indicator of Resilience in Patients with Headaches
Deborah I. Friedman, MD, MPH, FAHS University of Texas Southwestern |
| 12:05 pm – 12:15 pm | OR-14: There is No Sleeping it Off: The Impact of Poor Sleep in Children with Headache
Deirdre A. Caplin, PhD University of Utah |
| 11:15 am – 12:15 pm | CONCURRENT SESSION
Scientific Paper Presentations – Session 2B Includes Late-Breaking Abstract Presentations |
| 11:15 am – 11:25 am |
LBOR-01: Ahead of the Pain: Where We Stand After a Decade of Growth in Headache SubspecialistsSkyler L. Kanegi The University of Texas Health Science Center at San Antonio |
| 11:25 am – 11:35 am | LBOR-02: Drivers of Delayed Alcohol-Induced Headache: A Prospective-Cohort Study
David Garcia-Azorin, MD, PhD, MSci Hospital Clinico Universitario de Valladolid |
| 11:35 am – 11:45 am | LBOR-03: The Impact of Pre-Morbid Headaches on Headache Features and Long-Term Health Outcomes Post Traumatic Brain Injury: Insights from the American Registry for Migraine Research (ARMR)
Zachary Leibovit-Reiben, BS Mayo Clinic – Arizona |
| 11:45 am – 11:55 am | OR-15: A Case-Control Study of Continuous Headache in Youth with Migraine, Persistent Post-Traumatic Headache, and New Daily Persistent Headache
Carlyn A. Patterson Gentile, MD, PhD Children’s Hospital of Philadelphia, University of Pennsylvania |
| 11:55 am – 12:05 pm | OR-16: Trends in the Management of Headache Disorders in US Emergency Departments: Analysis of National Hospital Ambulatory Medical Care Survey 2007-2018 Data
Seonkyeong Yang, MS University of Florida |
| 12:05 pm – 12:15 pm | OR-17: Incidence of Status Migrainosus in Olmsted County, Minnesota, United States: Characterization and Predictors of Recurrence
Juliana VanderPluym, MD Mayo Clinic Arizona |
| 12:15 pm – 1:00 pm | DEBATE: Is Inflammation a Mechanism of Migraine?
Chair: Andrew F. Russo, PhD
Dan Levy, PhD, MSc Beth Israel Deaconess Medical Center
Andrew C. Charles, MD, FAHS University of California, Los Angeles |
| 1:00 pm – 2:15 pm | Exhibits and Poster Session
Lunch Available for Purchase |
| 1:00 pm – 2:00 pm | Industry-Sponsored Event
Setting the Bar Higher: Think You Know DHE? Think Again. Sponsored by Impel Pharmaceuticals Not Eligible for CME Credits Sara E. Sacco, MD Carolinas Headache Clinic
Deborah I. Friedman, MD, MPH, FAHS University of Texas Southwestern |
| 2:15 pm – 3:45 pm | Scientific Paper Presentations – Session 3
Includes Frontiers in Headache Research Scholarship |
| 2:15 pm – 2:25 pm | OR-18: Migraine Classification Using Deep Learning on Structural Brain MRI Data
Mahfuzur Rahman Siddiquee Arizona State University |
| 2:25 pm – 2:35 pm | OR-19: Anxiety and Depressive Symptoms and Disorders in Children and Adolescents with Migraine: A Systematic Review and Meta-Analysis
Serena L. Orr, MD, MSc Alberta Children’s Hospital |
| 2:35 pm – 2:45 pm | OR-20: Validation of Measures of Treatment Expectancy in Children & Adolescents with Headache
Christina L. Szperka, MD, FAHS Children’s Hospital of Philadelphia |
| 2:45 pm – 2:55 pm | OR-21: The Unique Role of Stigma in Migraine-Related Disability and Quality of Life
Elizabeth K. Seng, PhD Albert Einstein College of Medicine |
| 2:55 pm – 3:05 pm | OR-22: Glial Activation in Pain and Emotional Processing Regions in a Mouse Model of Chronic Migraine
Haley C. Cropper, BS University of Illinois at Chicago |
| 3:05 pm – 3:15 pm | OR-23: Examining the Test-Retest Consistency of Sensory Hypersensitivity Measures in Headache Subjects
Eric Tokita University of Utah |
| 3:15 pm – 3:25 pm | OR-24: Late Response to Anti-CGRP Monoclonal Antibodies Occurs in One-Third of Migraine Patients.
Piero Barbanti, MD, PhD IRCCS San Raffaele Roma |
| 3:25 pm – 3:35 pm | Frontiers in Headache Research Scholarship Presentation
Exploring the Neurobiology of the Premonitory Phase of Migraine Preclinically: Possible Involvement of Hypothalamic Kappa Opioid Receptor (KOR) Signaling Caroline Kopruszinski, PhD University of Arizona |
| 3:35 pm – 3:45 pm | Frontiers in Headache Research Scholarship Presentation
Headache Disability in Children and Adolescents Before and During The COVID-19 Pandemic Brian LaGrant, MD Children’s Hospital of Philadelphia |
| 3:45 pm – 5:45 pm | PLENARY: What Makes Migraine Worse
Moderator: Dawn C. Buse, PhD, FAHS Chair: Amynah A. Pradhan, PhD |
| 3:45 pm – 3:50 pm | Introductions
Eric A. Kaiser, MD, PhD University of Pennsylvania |
| 3:50 pm – 4:10 pm | Sleep
Emily Law, PhD University of Washington & Seattle Children’s Hospital |
| 4:10 pm – 4:15 pm | Q&A |
| 4:15 pm – 4:35 pm | Medication Overuse
Todd J. Schwedt, MD, MSCI, FAHS Mayo Clinic – Arizona |
| 4:35 pm – 4:40 pm | Q&A |
| 4:40 pm – 5:00 pm | Obesity
Dale S Bond, PhD Hartford Hospital/HealthCare |
| 5:00 pm – 5:05 pm | Q&A |
| 5:05 pm – 5:25 pm | Psychiatric Comorbidities
Todd A. Smitherman, PhD, FAHS University of Mississippi |
| 5:25 pm – 5:45 pm | Panel Discussion |
| 5:45 pm – 6:30 pm | John R. Graham Award Lecture
Introduction: Paul B. Rizzoli, MD, Clinical Director, John R. Graham Headache Center |
| Veni, Vidi, Ego conatus… In Memory of our Mentors
Peter J. Goadsby, MD, PhD, FAHS University of California, Los Angeles |
|
| 6:30 pm – 7:30 pm | Wine and Cheese Reception |
Sunday, June 12, 2022
| 7:00 am – 9:00 am | Registration Desk |
| 7:00 am – 8:00 am | Continental Breakfast |
| 8:00 am – 10:00 am | PLENARY: TBI/Post Traumatic Headache
Moderator: Alan G. Finkel, MD, FAHS Chair: Catherine D. Chong, PhD, FAHS |
| 8:00 am – 8:05 am | Introductions
Carlyn Patterson Gentile, MD, PhD Children’s Hospital of Philadelphia |
| 8:05 am – 8:25 am | Possible Mechanisms in the Origins of Post-Traumatic Headache
K.C. Brennan, MD University of Utah |
| 8:25 am – 8:30 am | Q&A |
| 8:30 am – 8:50 am | Imaging Migraine and Post-Traumatic Headache: Similarities and Differences
Catherine D. Chong, PhD, FAHS Mayo Clinic – Arizona |
| 8:50 am – 8:55 am | Q&A |
| 8:55 am – 9:15 am | Epidemiology of Post-Traumatic Headache within the Veterans Health Administration
Jason Sico, MD, MHS Veterans Health Administration |
| 9:15 am – 9:20 am | Q&A |
| 9:20 am – 9:40 am | Clinical Perspective on PTH
Tad Seifert, MD Norton Healthcare |
| 9:40 am – 10:00 am | Panel Discussion |
64th Annual Scientific Meeting
The late-breaking abstract site is now closed.
Authors will receive acknowledgment of receipt of abstracts via email and notification regarding acceptance on or before May 13, 2022.
Abstract FAQs
Do I need to indicate that my abstract has been submitted to other meetings/journals?
Yes. If the data submitted has been presented in total or in large part in the past, please note the date and place of the previous presentation(s).
Do you have an anticipated time for when abstract decisions will be sent out?
Notifications for late-breaking abstracts will go out by May 13, 2022.
Can I get an extension on the abstract submission deadline?
Due to the review process and timeline, extensions are not permitted.
Is there an abstract submission fee?
No, there is no submission fee.
Do you accept industry abstracts?
Yes. Industry abstracts need to be identified and are not eligible for CME credits. Abstracts submitted by industry will be considered in separate categories from other abstracts. Industry abstracts fall into two categories:
1) Industry-initiated Clinical Trials
2) industry-initiated Research Involving Drugs, Devices, or other Products with a Commercial Interest. This category will not include investigator-initiated studies that may have industry support.
Will abstracts be published? If yes, when and where?
Accepted abstracts will be published in the journal, Headache®. They are typically in the June edition or sent as a supplement to the June edition.
Is there a limit on how many abstracts an author can submit or present?
No, there is no limit. However, for industry abstracts from the same study, we strongly recommend combining them into fewer abstracts.
Do you allow encores?
Yes. You can submit an abstract that has previously been presented within the last year as long as it is the same data and information. All “Encore” submissions will be reviewed by the selection committee and authors will be notified if they have been accepted.
What is the embargo policy?
All content and data is embargoed until June 8, 2022 @11:59 pm MT.
When and where can I view abstracts?
Abstracts will be available to view in the mobile app and in the journal, Headache®.
Are there text abstracts available?
Yes, in the journal, Headache®.
When will AHS abstracts be publicly available?
They are available starting June 9, 2022 @ 12am MT. They will be published in the journal, Headache®, as well as through the meeting’s mobile app.
How do I register for the meeting?
All accepted abstract lead/presenting authors will receive a special set of instructions with their acceptance notice including information on how to register for the meeting.
Are lead/presenting authors required to register for the meeting?
If you plan to present at the meeting (either in-person or virtually), you must register for the meeting.
What if the lead/presenting author cannot attend the meeting?
If this arises, AHS will allow one of the other authors to register and present on their behalf.
Do poster presenters need to register for the meeting?
Yes, poster presenters must register.
AHS Policy on Industry Submitted Abstracts (PDF)
Still have questions? Please click here to contact AHS Headquarters via email.
64th Annual Scientific Meeting
CONGRATULATIONS TO THE 2022 ANNUAL AWARD RECIPIENTS!
Above & Beyond Awards |
|
 |
Stephanie J. Nahas, MD, MSEd, FAHS Thomas Jefferson University Philadelphia, PA |
 |
Duren Michael Ready, MD, FAHS Baylor Scott & White Clinic Temple, TX |
 |
Adam Sprouse Blum, MD University of Vermont Medical Center Burlington, VT |
Distinguished Service Award |
|
 |
William B. Young Jr., MD, FAHS Thomas Jefferson University Hospital Philadelphia, PA |
Join us during the AHS Membership Meeting on Thursday, June 9 from 4:45 – 5:30 PM MDT in Adams A for Above and Beyond and Distinguished Service award presentations.
View additional Above and Beyond Award information here
View additional Distinguished Service Award information here.
Seymour Solomon Lecture Award |
|
 |
Larry Charleston IV, MD, MS, FAHS Michigan State University College of Human Medicine East Lansing, MI |
Join us on Friday, June 10 from 8:00 – 8:45 AM MDT in Adams A for the Seymour Solomon lecture and award presentation.
View additional Solomon Award information here.
Lifetime Achievement Award |
|
 |
Gretchen E. Tietjen, MD University of Toledo Toledo, OH |
Join us on Friday, June 10 from 8:45 – 9:00 AM MDT in Adams A for the Lifetime Achievement award presentation.
View additional Lifetime Achievement Award information here.
Early Career Award |
|
 |
Chia-Chun Chiang, MD Mayo Clinic Rochester, MNMigraine with Aura Associates with A Higher Artificial Intelligence- ECG Atrial Fibrillation Prediction Model Output Compared to Migraine without Aura in Both Women and Men |
Join us on Friday, June 10 from 1:00 – 1:30 PM MDT in Adams A for the Early Career lecture and award presentation.
View additional Early Career Award information here.
Harold G. Wolff Award |
|
 |
Amynah Pradhan, PhD University of Illinois at Chicago Chicago, ILMigraine and peripheral pain models show differential alterations in neuronal complexity |
Join us on Friday, June 10 from 2:30 – 3:15 PM MDT in Adams A for the Harold G. Wolff lecture and award presentation.
View additional Wolff Award information here.
View Headache Journal Interview here.
John R. Graham Lecture Award |
|
 |
Peter J. Goadsby, MD, PhD, FAHS University of California, Los Angeles UCLA Goldberg Migraine Program Los Angeles, CA |
Join us on Saturday, June 11 from 5:45 – 6:30 PM MDT in Adams A for the John R. Graham lecture and award presentation.
View additional Graham Award information here.
“Frontiers in Headache Research” Scholarship Awards |
| Platform Presenters: |
| Paige M. Estave, PhD Wake Forest School of Medicine Winston Salem, NC |
| Caroline Machado Kopruszinski, PhD University of Arizona Tucson, AZ |
| Brian LaGrant, MD Children’s Hospital of Philadelphia Philadelphia, PA |
| Poster Presenters: |
| Mai-Lynn Bui, DO University of South Florida Tampa, FL |
| Jay M. Dave, DO Robert Wood Johnson University Hospital, Department of Neurology New Brunswick, NJ |
| Andrew Day, MD NYU Grossman School of Medicine New York, NY |
| Lucia Liao, MD Thomas Jefferson University Philadelphia, PA |
| Riya Luhar, DO Hartford Healthcare Headache Center West Hartford, CT |
| Katrina M. Nayak, MD Case Western Reserve/University Hospital Cleveland, OH |
| Ann Oh, MD University of Colorado Anschutz Medical Campus Denver, CO |
| Peter B. Soh, MD, MPH Hartford Healthcare Headache Center West Hartford, CT |
Join us on Friday, June 10 from 11:15 AM – 1:00 PM MDT in Adams A for scholarship and award presentations during Scientific Paper Presentations – Session 1.
Join us on Saturday, June 11 from 11:15 AM – 12:15 PM MDT in Adams A for scholarship presentations during Scientific Paper Presentations – Session 2B and from 2:15 pm – 3:45 PM during Scientific Paper Presentations – Session 3.
View additional “Frontiers in Headache Research” Award information here.
Runnin’ for Research Advocacy Awards |
| Attending the 64th Annual Scientific Meeting: |
| Anastasia Railean, MD Wake Forest Atrium Health Lewisville, NC |
| Attending the 2022 Scottsdale Headache Symposium®: |
| Jessalyn Shen, MD Montefiore Medical Center Bronx, NY |
Members’ Choice Award for the best Headache Article of 2021
Management of primary headaches during pregnancy, postpartum, and breastfeeding: A systematic review (Ian J. Saldanha MBBS, MPH, PhD, Wangnan Cao PhD, Monika Reddy Bhuma BDS, MPH, Kristin J. Konnyu PhD, Gaelen P. Adam MLIS, MPH, Shivani Mehta BA, Andrew R. Zullo PharmD, PhD, Kenneth K. Chen MD, Julie L. Roth MD, Ethan M. Balk MD, MPH)
View additional information about the Members’ Choice Award here.
View the Headache Journal interview here.
64th Annual Scientific Meeting
SPONSORSHIP AND EXHIBIT INFORMATION
The Sponsorship Portal is now open! Visit to book your support today!
View the Sponsorship and Exhibit Prospectus
View the Exhibit Hall Floor Plan and Booth Listing
View Exhibit Hall Hours
NEW SPONSORSHIP OPTIONS FOR 2022:
- Hydration Package: Place your logo on a branded metal water bottle given to all attendees. Reduce waste and create an item that will be reused. AHS will produce these items.
- AHS Has Talent Sponsorship: Become the key sponsor for the AHS Talent Show on Friday night. Feature your logo on stage and in the program as meeting attendees showcase their secret talents (also features light refreshments).
- In House-TV: Put your company on TV! Use the hotel’s In-Room TV channel to provide excellent coverage for your company and products. Get creative with a 72-hour loop (Thur-Sat) of your content playing in every hotel room.
- Wellness Sponsor: Help attendees start the day on the right foot by sponsoring our new sunrise yoga sessions. This includes a gift of a branded yoga mat that each attendee takes home.
- *NEW* Industry-Sponsored Symposium First Choice: This exclusive Industry Symposium sponsorship will guarantee you your first choice of time/dates (from the AHS provided list). You will also receive extra promotions throughout the conference space. Use our Exhibit and Sponsorship portal to select a sponsorship opportunity (booth included) or purchase an exhibit booth without sponsorship. You can also purchase additional sponsorship opportunities.
ALSO NEW FOR 2022
Submitting your applications for industry events and ancillary meetings is easier! All submissions and payments can be made directly in the exhibit and sponsorship portal. Simply select the industry or ancillary event as an item to purchase and then complete the necessary “tasks” in the portal. Once the tasks are completed and your application is approved, you will be notified and sent an invoice to complete directly in the portal.
INDUSTRY SUPPORTED EVENTS
Add your organization to those sharing research and product news with a Satellite Symposium. We have openings from Thursday to Saturday. These events take place without conflict of other CME sessions and will be advertised in the Final Program.
You can offer a presentation with or without CME (you will be responsible for securing your own CME provider) and choose to serve food in your private room with space for over 100 attendees. You must have an FDA-approved product/service.
View CME Event Objectives & Guidelines here
View Non-CME Event Policy & Guidelines here
If you are not exhibiting or sponsoring the meeting but would like to request space for a meeting, please contact Heidi Jetter at hjetter@talley.com.
The American Headache Society gratefully acknowledges the support of the 64th Annual Scientific Meeting from our industry supporters:
PLATINUM
We’re a company that takes on the toughest health challenges. But we do more than treat diseases—we aim to make a remarkable impact on people’s lives. We are AbbVie, a highly focused research-driven biopharmaceutical company. |
Amgen is committed to unlocking the potential of biology for patients suffering from serious illness by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. |
Biohaven is a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases. The Company has two small molecule calcitonin gene-related peptide (CGRP) receptor antagonist product candidates in development, rimegepant and vazegepant, for acute and preventive treatment of migraine. Rimegepant, the lead candidate, is an orally-administered, rapidly dissolving single dose CGRP with a novel mechanism that targets the underlying pathophysiology of migraine without causing vasoconstriction. |
Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded in 1876 by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission. |
Lundbeck, a global pharmaceutical company based in Denmark and founded in 1915, is tirelessly dedicated to restoring brain health, so every person can be their best. Lundbeck has a long heritage of innovation in neuroscience and is focused on delivering transformative treatments that address unmet needs in brain health. |
SILVER
     |
BRONZE
 Axsome Therapeutics, Inc. is developing therapies for CNS conditions with limited treatment options. By creating treatments with novel mechanisms of action, we are transforming the approach to treating CNS conditions. At Axsome, we are committed to developing therapeutic approaches that meaningfully improve the lives of patients and provide additional options for physicians. |
AHS gratefully acknowledges the educational grant support of the 64th Annual Scientific Meeting from our industry supporters:
| Lilly USA, LLC |
| Lundbeck LLC |
64th Annual Scientific Meeting
HOTEL
**UPDATE MAY 13**
The hotel block is now closed. If you need to make or modify your reservations, please contact the hotel directly
*******
Gaylord Rockies Resort
6700 N. Gaylord Rockies Blvd
Denver, CO
Standing at the edge of the Front Range, Gaylord Rockies Resort & Convention Center showcases the state’s alpine charm and offers guests a welcome reprieve from the typical mountain resort stay. From our thrilling Arapahoe Springs Water Park, to an exciting lineup of family-friendly activities and entertainment, there’s something for the entire family to enjoy. Guests can explore the beautiful Grand Lodge and its stunning mountain views, five delicious restaurants, bars, the world-class Relâche Spa, and a state-of-the-art fitness center. With a fantastic water park, seasonal events, entertainment, and close proximity to local attractions, Gaylord Rockies Resort is the place where you can enjoy more of everything you love.
The group room rate at the Gaylord Rockies Resort for AHS participants is $249.00 for a single or double room, plus prevailing taxes. Room reservations and rates are available on a first-come, first-served basis until Thursday, May 12, 2022, or until the room block is sold out, whichever comes first. After that date, reservation requests will be based on the hotel’s prevailing rate. All reservations must be guaranteed with a credit card. There is a special link to book your room in the registration confirmation email.
Reservations within the AHS block of rooms are for registered attendees ONLY. Reservations made by non-registrants will not receive the discounted rate and may be canceled.
64th Annual Scientific Meeting
Congratulations to those abstracts accepted as posters. We know this is an exciting time and that you may have questions. Please read the FAQ’s below:
How Do I Accept My Invitation to Present a Poster?
Please look for the link in our email to you. Use that to login to our Poster Collection Platform and accept our invitation. You will also use this platform to upload a digital copy of your poster. We will use this on the mobile app and virtual event website. Please accept your poster presentation by Friday, April 15, 2022.
Are Presenting Authors Required to Register for the Meeting?
If you plan to present/defend your poster at the meeting, you must register. All accepted abstract presenting authors will receive instructions with their acceptance notice with information on how to register for the meeting.
What if I Can’t Be There in Person?
We understand that not everybody can join us in Denver. Therefore, if you choose the Virtual Attendance Experience, you can still have one of your colleagues hang your physical poster. However, you will not have the opportunity to answer live questions from the attendees.
Is There a Discount for Poster Authors?
Yes, presenting authors can take advantage of an extended early bird rate until April 15. When entering the Poster Collection Portal, look for the “Registration” task.
How Do I Book My Hotel Room?
After you register, you will receive a link to book a hotel room in your registration confirmation email. The hotel cut-off is May 13 at 5 pm MT or until the block sells out, whichever comes first.
When Can I Hang My Poster/When Does it Have to Come Down By?
Posters should be hung on the assigned board between 2:00 pm – 4:00 pm on Thursday, June 9. Posters should not be removed before 2:30 pm on Saturday, June 11. Any poster left after 5:00 pm on Saturday, June 11, may be discarded.
When Should I be at my Poster for the Q & A Session?
Poster presenters with an ODD Poster number should be available at their poster between 1:30 pm – 2:30 pm on Friday, June 10. Poster presenters with an EVEN poster number should be available between 1:00 pm – 2:15 pm on Saturday, July 11.
How Can I Print and Ship My Poster?
AHS is offering a special poster printing opportunity via MakeSigns.
This includes discounted printing prices and free shipping of your poster to the meeting venue or your office. Although this is not mandatory, we suggest you take advantage of this service.
- The benefits of using the poster printing program include:
- The poster can ship to the meeting. Pick it up onsite and avoid the inconvenience of carrying it to the meeting.
- Free templates are available for download to make the poster creation process easy.
- Customer support is available to assist with questions.
Please note if you select to print your poster via MakeSigns, you will still need to be present to mount your poster.
To take advantage of our special package, click here.
If you want to print the poster with another company, please use these guidelines
- Recommended poster size: 72″W x 36″H
- MAX poster size: 91″W x 45″H
- Poster board space: 96″W x 48″H (8′ x 4′)
- Media Type: No restrictions (presenters can choose matte, glossy or fabric)
To ship your poster directly, please address it like this:
Gaylord Rockies Resort & Convention Center
Hold for Guest: (Guest Name) (Arrival Date)
(Guest Cell Number)
6700 N. Gaylord Rockies Blvd
Aurora, CO 80019
64th Annual Scientific Meeting
Welcome to the American Headache Society’s64th Annual Scientific Meeting Press Room. Here you can find the latest news releases related to the meeting, as well as press guidelines for media professionals, exhibitors, presenters and satellite symposia organizers.
Please contact the American Headache Society for all media-related questions, including obtaining press passes, at ahshq@talley.com or 856-423-0043.
64th Annual Scientific Meeting
Missed the 64th Annual Scientific Meeting? Registration is available for the On Demand Experience through December 2022.
Once registered, access the 64th Annual Scientific Meeting in the palm of your hand on your phone, tablet or computer:
Access all live and on-demand sessions and slides
Ask questions of speakers in real-time
Connect with in-person and virtual attendees
Explore the exhibit hall 24-7
Obtain CME credit after completing the evaluation
Download the app from the Apple App Store here
Download the app from the Google Play store here
Access the Annual Scientific Meeting on your computer here
Download our How-To Guide here for step-by-step instructions, or follow the below steps to login to the app or event website:
- Click Login in the upper right-hand corner
- Enter the email you used to register for the Annual Scientific Meeting
- Create a password
- If you have already created an account and forgot your password, click “send me a magic link” for an email to reset your password
- Enter the 64th Annual Scientific Meeting event, explore, and enjoy!
- If you need technical assistance once in the app or event website, click the “Tech Help Desk” button or follow this link
- If you still require assistance, email us at ahshq@talley.com and we’ll connect you with a tech specialist who can help
- Watch the below video for a tutorial on navigating the event through the app or website (from the 2021 Scottsdale Headache Symposium):
64th Annual Scientific Meeting
Scientific Program Committee
Chair
| Amynah Pradhan, PhD University of Illinois at Chicago Chicago, Illinois |
Committee Members
| Jessica Ailani, MD, FAHS MedStar Georgetown University Hospital Washington, District of Columbia |
Andrew Russo, PhD University of Iowa Iowa City, Iowa |
| Mark J. Burish, MD, PhD University of Texas Health Science Center at Houston Houston, Texas |
Elizabeth Seng, PhD, FAHS Yeshiva University/Albert Einstein College of Medicine Bronx, New York |
| Catherine D. Chong, PhD, FAHS Mayo Clinic Phoenix, Arizona |
Christina L. Szperka, MD, FAHS Children’s Hospital of Philadelphia Philadelphia, Pennsylvania |
| Deborah I. Friedman, MD, MPH, FAHS UT Southwestern Medical Center Dallas, Texas |
Juliana VanderPluym, MD, FAHS Mayo Clinic Phoenix, Arizona |
64th Annual Scientific Meeting
AHS members are invited to participate in Special Interest Section meetings that will be held in-person and virtually via Zoom. All Zoom details have been distributed via Outlook calendar invites. Zoom links are also listed in the calendar below. If you experience any technical difficulties, please contact AHSHQ@Talley.com.
64th Annual Scientific Meeting
Below are a list of important dates and deadlines for the 64th Annual Scientific Meeting. Please contact the AHS Team (ahshq@talley.com) with any questions:
- Registration
- Early-Bird: Before April 8
- Regular Registration: April 8 – June 7
- Late Registration: June 8 – June 12
- Hotel
- Last day to guarantee the AHS group rate: May 12
- Scientific Abstracts
- Abstract submissions close on February 17, 2022, 11:59 pm Hawaii Standard Time (February 18, 2022, 4:59 am Eastern Standard Time)
- Submissions acceptance notices sent by April 1, 2022
- Frontiers in Headache Research Scholarship Awards
- Call for applications opens: January 10, 2022
- Application deadline: February 28, 2022
- Runnin’ for Research Advocacy Award
- Call for applications opens: January 31, 2022
- Application deadline: March 7, 2022
- Members’ Choice Award
- Call for votes opens: March 1, 2022
- Voting deadline: March 31, 2022